Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 381 - 400 of 465
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  Courts do not require companies to be pessimistic in assessing arguably negative results; they merely require that companies be honest in their statements and forthcoming with the relevant underlying facts. [read post]
14 Dec 2017, 10:48 pm by GJEL
The remaining manufacturers, including Bristol-Myers Squibb, ultimately settled for $3.4 billion, and Dow Corning resolved its claims in bankruptcy court. [read post]
5 Mar 2024, 11:47 am by Kurt R. Karst
PLAINTIFF COURT AND DATE OF COMPLAINT SELECTED DRUGS (FOR YEAR 2026) Bristol Myers Squibb D.N.J. (16 June 2023) Eliquis Novartis D.N.J. (1 Sept. 2023) Entresto J&J’s Janssen Pharms. [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline,… [read post]
25 Jan 2023, 1:37 pm by Kevin LaCroix
The settlement listed in the hundred spot on the list is 2006 settlement of $185 million in the Bristol-Myers Squibb Co. case. [read post]
9 Dec 2009, 3:59 pm
 (Patent Docs) (SmartBrief) (GenericsWeb) OxyContin (Oxycodone) – US: Ranbaxy admits infringement in OxyContin suit – District Court S D New York approves consent judgment between Ranbaxy and Purdue Pharma (Patent Docs) Reyataz (Atazanavir) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Bristol-Myers Squibb Co. et al. v. [read post]
12 Jun 2018, 6:56 am by Joy Waltemath
The agency’s argument that the regulation leaves the decision up to the employer was unavailing, the court explained, under the competitor standing doctrine and had already been rejected in earlier cases, such as Bristol-Myers Squibb Co. v. [read post]
4 Oct 2023, 10:00 pm by Kurt R. Karst
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
29 Jul 2009, 6:45 am
(Patent Circle) India: ‘In transit’ drug seizures and TRIPS: UK decision may help Indian companies (Spicy IP) India: Public interest litigation to prevent GM seeds in India (IP Osgoode) Isle of Man: SPCs on the Isle of Man (The SPC Blog) US: Board decision in Ex Parte Roberts doesn’t make the cut (Patents4Life) US: Are you getting all the patent term you should? [read post]
27 Jan 2012, 1:18 pm by Robert McKennon
CDI also filed lawsuits against pharmaceutical company Bristol-Myers Squibb for showering doctors with illegal kickbacks to get them to write more prescriptions and against Sutter Hospitals for bogus anesthesia billings. [read post]
15 Oct 2012, 1:24 am by Kevin LaCroix
It is not even the largest securities suit settlement, having been exceeded, among others, by Bristol Myers Squibb’s $300 million securities lawsuit settlement (about which refer here). [read post]
3 Dec 2008, 2:00 pm
But there are potential pitfalls lurking, including one case involving Bristol-Myers Squibb's blood thinner Plavix and AstraZeneca's heartburn drug Prilosec. [read post]
26 Oct 2022, 3:17 am by Cari Rincker
(Nov. 24, 2021), https://ag.ny.gov/press-release/2021/attorney-general-james-secures-51-million-judgment-against-new-york-city-stem. [5] $834 Million Order Entered in Hawai‘i State Court against Bristol-Myers Squibb and Sanofi for Failing to Investigate and Disclose Ineffectiveness of Plavix®, Dept. of the Att’y Gen. [read post]
Then, led by a passion for helping bring teams together, I moved into my first DEI role at Bristol-Myers Squibb in 2002. [read post]